您的位置: 首页 > 农业专利 > 详情页

RNAi agents and inhibitors of C-III (APOC3).
专利权人:
ARROWHEAD PHARMACEUTICALS; INC.
发明人:
ZHU, Rui,PEI, Tao,LI, Zhen,KANNER, Steven,WONG, So
申请号:
CL2020000593
公开号:
CL2020000593A1
申请日:
2020.03.09
申请国别(地区):
CL
年份:
2020
代理人:
摘要:
T. Oacute; n refers to the agent of iarn, such as the double Hebrew agent of iarn, which can inhibit the expression of amp; oacute; n is the gene from apolipoproterate and amp; Iacute; Na C-III (tambi amp; eacute; n is called APOC3, apoC-III, apoC-III and apo C-III),There are also works by iarn agents for APOC3 The APOC3 staff of iarn in Aqua amp and Iacute can be merged into the targeted alliance, including n-acetyl-galatosamina, to promote CI amp, oacute, N-C amp, eacute, Lulas, including hep bromine cells. Tambi amp; eacute; n describes the ingredients of pharmacy and amp; eacute; medicinal materials including one or one M amp; Aacute; APOC3 agents of Aacute; iarn can choose one or one of M amp; Aacute; s therapists amp agents; eacute; extra props. Administration and provincial agencies; oacete; n de la expui amp; oacute; n de UN Gen de APOC3,The results may be that the subjects had lower levels of M amp, Aacute, trigic amp, eacute, ridis and / or cholesterol. Iarn preparations for the treatment of APOC3 can be used in M amp; eacute; all preparations for the treatment of APOC3 related diseases and diseases, including hypertension, cardiovascular diseases and other metabolic diseases and diseases.<;p>;La presente divulgació;n se refiere a agentes de iARN, por ejemplo agentes de iARN de doble hebra, capaces de inhibir la expresió;n de genes de apolipoproteí;na C-III (tambié;n denominada APOC3, apoC-III, APOC-III y APO C-III), y a composiciones que incluyen agentes de iARN para APOC3. Los agentes de iARN para APOC3 divulgados aquí; pueden ser conjugados a ligandos de direccionamiento, incluyendo ligandos que incluyen N-acetil-galactosamina, para facilitar la administració;n a cé;lulas, incluyendo a hepatocitos. Tambié;n se describen composiciones farmacé;uticas que incluyen uno o má;s agentes de iARN para APOC3, opcionalmente con uno o má;s agentes terapé;uticos adicionales
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充